Getting the priorities right for stroke care

BMJ (Online)

Volumn 338, Issue 7708, 2009, Pages 1419-1422

  Sudlow, Cathie ^a   Warlow, Charles ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; PRIORITY JOURNAL; STROKE PATIENT; UNITED KINGDOM;

ACUTE DISEASE; FIBRINOLYTIC AGENTS; GREAT BRITAIN; HEALTH PRIORITIES; HOSPITAL UNITS; HUMANS; INTENSIVE CARE; PATIENT EDUCATION AS TOPIC; RISK ASSESSMENT; STATE MEDICINE; STROKE; TREATMENT OUTCOME;

EID: 67650047693     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Department of Health. National stroke strategy. London: DoH, 2007. www.dh.gov.uk (search for 9025).
2. Department of Health. Reducing brain damage: faster access to better stroke care. London: National Audit Office, 2005. www.nao.org.uk/publications/ 0506/reducing-brain-damage.aspx.
3. Markus H. Improving the outcome of stroke. BMJ 2007;335:359-60.
4. Coombes R. Watchdog finds that NHS is failing stroke patients. BMJ 2005;331:1161.
5. Healthcare for London. Stroke strategy for London. 2008. www.healthcareforlondon.nhs.uk/assets/ Publications/Stroke/ London20stroke20strategywebversionFINAL.pdf.
6. Clinical and Effectiveness Evaluation Unit, Royal College of Physicians. National sentinel stroke audit phase II (clinical audit) 2008. London: RCP, 2009. www.rcplondon.ac.uk/ clinical-standards/ceeu/Current-work/stroke/ Documents/ stroke-audit-report-2008.pdf.
7. Boyle R. The national stroke strategy: direction of travel and quality markers for stroke rehabilitation service development in England. 2009. www.healthcareforlondon.nhs.uk/assets/Publications/Stroke/ The-National-Stroke- Strategy-Direction-of-travel.ppt.
8. Dudley N, Blacktop J. The hype in hyperacute stroke. Age Ageing 2008;37:236.
9. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;(4):CD000197.
10. Sandercock PAG, Counsell C, Gubitz GJ, Tseng M-C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2008;(3):CD000029.
11. Wardlaw JM, del Zoppo GJ, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003;(3):CD000213
12. Thrombolytic therapy with alteplase for ischaemic stroke. Drug Ther Bull 2009;47:14-8.
13. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-33.
14. Stewart JA, Dundas R, Howard RS, Rudd AG, Wolfe CD. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ 1999;318:967-71.
15. Syme PD, Byrne AW, Chen R, Devenny R, Forbes JF. Community-based stroke incidence in a Scottish population: the Scottish Borders Stroke Study. Stroke 2005;36:1837-43.
16. King's College London. Economic burden of stroke in England. National Audit Office, 2005.
17. Thrift AG, Dewey HM, Macdonell RA, McNeil JJ. Donnan GA. Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke 2001;32:1732-8.
18. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs and effects on individuals and populations. Lancet 1999;354:1457-63.
19. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773-83.
20. Warlow C, van Gijn J, Dennis M, Wardlaw J, Bamford J, Hankey G, et al. What is this patient's prognosis? In: Stroke: practical management. 3rd ed. Oxford: Blackwell Publishing, 2008:509.
21. BMJ, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMJ, RPS, 2009. (No 57.)
22. Third international stroke trial. http://controlled-trials.com/ ISRCTN25765518.